Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tinnitus | 9 | 2020 | 148 | 4.00 | Why? |
| Hearing Loss | 7 | 2018 | 225 | 2.15 | Why? |
| Hearing Loss, Sensorineural | 6 | 2020 | 159 | 1.71 | Why? |
| Hyperacusis | 3 | 2018 | 12 | 1.68 | Why? |
| Hearing | 4 | 2018 | 87 | 1.68 | Why? |
| Homeless Persons | 5 | 2021 | 1171 | 1.66 | Why? |
| Otolaryngology | 8 | 2021 | 1917 | 1.53 | Why? |
| Neuroma, Acoustic | 2 | 2018 | 10 | 1.49 | Why? |
| Head and Neck Neoplasms | 4 | 2020 | 1568 | 1.30 | Why? |
| Temporomandibular Joint Disorders | 2 | 2018 | 77 | 1.27 | Why? |
| Hearing Loss, Noise-Induced | 3 | 2018 | 15 | 1.10 | Why? |
| Housing | 3 | 2021 | 1146 | 1.09 | Why? |
| Otorhinolaryngologic Surgical Procedures | 2 | 2020 | 657 | 1.01 | Why? |
| Vestibular Evoked Myogenic Potentials | 2 | 2018 | 10 | 0.96 | Why? |
| Ear, Inner | 2 | 2018 | 19 | 0.92 | Why? |
| Phonation | 2 | 2019 | 49 | 0.92 | Why? |
| Temporal Bone | 2 | 2018 | 37 | 0.87 | Why? |
| Music | 2 | 2019 | 107 | 0.81 | Why? |
| Labyrinth Diseases | 2 | 2018 | 12 | 0.80 | Why? |
| Motor Neurons | 1 | 2019 | 52 | 0.79 | Why? |
| Musculoskeletal Diseases | 2 | 2017 | 646 | 0.78 | Why? |
| Hearing Tests | 2 | 2018 | 76 | 0.77 | Why? |
| Meniere Disease | 1 | 2018 | 14 | 0.76 | Why? |
| Dental Clinics | 1 | 2020 | 149 | 0.75 | Why? |
| Child Language | 1 | 2018 | 23 | 0.75 | Why? |
| Vatican City | 4 | 2021 | 19 | 0.75 | Why? |
| Adenoma, Pleomorphic | 1 | 2018 | 10 | 0.74 | Why? |
| Endolymphatic Hydrops | 1 | 2017 | 4 | 0.74 | Why? |
| Pharyngeal Neoplasms | 1 | 2018 | 17 | 0.74 | Why? |
| Sleep Apnea, Obstructive | 4 | 2019 | 668 | 0.73 | Why? |
| Vestibule, Labyrinth | 1 | 2017 | 8 | 0.73 | Why? |
| Neonatal Screening | 2 | 2018 | 285 | 0.72 | Why? |
| Lipoma | 1 | 2017 | 15 | 0.71 | Why? |
| Somatosensory Cortex | 1 | 2017 | 9 | 0.71 | Why? |
| Hearing Disorders | 1 | 2018 | 62 | 0.69 | Why? |
| Transcranial Direct Current Stimulation | 1 | 2017 | 107 | 0.64 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2018 | 161 | 0.62 | Why? |
| Speech | 1 | 2018 | 241 | 0.59 | Why? |
| Otolaryngologists | 1 | 2020 | 533 | 0.58 | Why? |
| Carcinoma | 1 | 2018 | 256 | 0.56 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 398 | 0.52 | Why? |
| Hearing Loss, Sudden | 3 | 2020 | 103 | 0.50 | Why? |
| Occupational Diseases | 2 | 2018 | 2787 | 0.48 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.48 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.48 | Why? |
| Otorhinolaryngologic Diseases | 1 | 2018 | 491 | 0.47 | Why? |
| Pediatrics | 4 | 2019 | 2969 | 0.44 | Why? |
| Early Diagnosis | 3 | 2018 | 2443 | 0.43 | Why? |
| Vertigo | 3 | 2020 | 141 | 0.40 | Why? |
| Otitis Media with Effusion | 2 | 2019 | 39 | 0.38 | Why? |
| Cochlea | 2 | 2018 | 23 | 0.38 | Why? |
| Temporomandibular Joint | 2 | 2018 | 24 | 0.36 | Why? |
| Multiple Sclerosis | 3 | 2018 | 2600 | 0.35 | Why? |
| Transients and Migrants | 1 | 2020 | 1468 | 0.35 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.34 | Why? |
| Magnetic Resonance Imaging | 4 | 2018 | 6551 | 0.33 | Why? |
| Ophthalmology | 1 | 2020 | 1840 | 0.31 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.30 | Why? |
| Physician's Role | 3 | 2019 | 853 | 0.30 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.30 | Why? |
| Olfaction Disorders | 2 | 2020 | 3704 | 0.28 | Why? |
| Neck | 2 | 2017 | 307 | 0.28 | Why? |
| Humans | 73 | 2021 | 930598 | 0.28 | Why? |
| Neuromyelitis Optica | 2 | 2019 | 397 | 0.26 | Why? |
| Italy | 11 | 2021 | 38444 | 0.25 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.24 | Why? |
| Audiometry | 2 | 2018 | 30 | 0.24 | Why? |
| Epistaxis | 2 | 2020 | 96 | 0.24 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Quality of Life | 3 | 2019 | 9820 | 0.22 | Why? |
| Disease Management | 3 | 2020 | 6841 | 0.22 | Why? |
| Sambucus nigra | 1 | 2019 | 2 | 0.21 | Why? |
| Riluzole | 1 | 2019 | 5 | 0.21 | Why? |
| Galactans | 1 | 2019 | 11 | 0.21 | Why? |
| Lactobacillus acidophilus | 1 | 2019 | 8 | 0.20 | Why? |
| Streptococcus oralis | 1 | 2019 | 4 | 0.20 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.20 | Why? |
| Narrow Band Imaging | 1 | 2019 | 24 | 0.20 | Why? |
| Streptococcus salivarius | 1 | 2019 | 6 | 0.20 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.20 | Why? |
| Maternal Age | 1 | 2021 | 244 | 0.20 | Why? |
| Glottis | 1 | 2019 | 48 | 0.20 | Why? |
| Diagnosis, Differential | 3 | 2019 | 7220 | 0.20 | Why? |
| Auditory Pathways | 1 | 2018 | 3 | 0.19 | Why? |
| Antibiosis | 1 | 2019 | 26 | 0.19 | Why? |
| Cochlear Nerve | 1 | 2018 | 4 | 0.19 | Why? |
| Skull | 1 | 2019 | 48 | 0.19 | Why? |
| Frontal Sinusitis | 1 | 2018 | 13 | 0.19 | Why? |
| Spiral Ganglion | 1 | 2018 | 13 | 0.19 | Why? |
| Superantigens | 1 | 2019 | 53 | 0.19 | Why? |
| Rhinoscleroma | 1 | 2018 | 3 | 0.19 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.19 | Why? |
| Sound | 1 | 2018 | 43 | 0.19 | Why? |
| Staphylococcus | 1 | 2019 | 77 | 0.18 | Why? |
| Evoked Potentials, Auditory, Brain Stem | 1 | 2018 | 42 | 0.18 | Why? |
| Amyloidosis | 1 | 2020 | 178 | 0.18 | Why? |
| Neoplastic Stem Cells | 1 | 2019 | 120 | 0.18 | Why? |
| Otoacoustic Emissions, Spontaneous | 1 | 2018 | 46 | 0.18 | Why? |
| Graves Ophthalmopathy | 1 | 2018 | 28 | 0.18 | Why? |
| Noise, Occupational | 1 | 2017 | 15 | 0.18 | Why? |
| Neuropeptides | 1 | 2019 | 91 | 0.18 | Why? |
| Neuronal Plasticity | 1 | 2018 | 98 | 0.18 | Why? |
| Cell Count | 1 | 2018 | 228 | 0.18 | Why? |
| Male | 26 | 2021 | 367725 | 0.18 | Why? |
| Otitis Media, Suppurative | 1 | 2017 | 5 | 0.17 | Why? |
| Transforming Growth Factor beta1 | 1 | 2019 | 204 | 0.17 | Why? |
| Vibration | 1 | 2018 | 68 | 0.17 | Why? |
| Posture | 1 | 2019 | 199 | 0.17 | Why? |
| Oral Ulcer | 1 | 2018 | 70 | 0.17 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.17 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.17 | Why? |
| Singing | 1 | 2019 | 143 | 0.17 | Why? |
| Lymphedema | 1 | 2017 | 44 | 0.17 | Why? |
| Eye Movements | 1 | 2017 | 41 | 0.17 | Why? |
| Paresthesia | 1 | 2017 | 134 | 0.17 | Why? |
| Takayasu Arteritis | 1 | 2017 | 83 | 0.17 | Why? |
| Postural Balance | 1 | 2018 | 144 | 0.16 | Why? |
| Microsurgery | 1 | 2019 | 166 | 0.16 | Why? |
| Glioma | 1 | 2019 | 189 | 0.16 | Why? |
| Laryngeal Neoplasms | 1 | 2019 | 202 | 0.16 | Why? |
| Estrogens | 1 | 2020 | 252 | 0.16 | Why? |
| Laser Therapy | 1 | 2019 | 158 | 0.16 | Why? |
| Sex Factors | 3 | 2019 | 11014 | 0.16 | Why? |
| Vestibular Diseases | 1 | 2017 | 68 | 0.16 | Why? |
| Behcet Syndrome | 1 | 2018 | 136 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Neck Pain | 1 | 2017 | 126 | 0.15 | Why? |
| Noise | 1 | 2018 | 194 | 0.15 | Why? |
| Nasal Polyps | 1 | 2019 | 221 | 0.15 | Why? |
| Movement | 1 | 2018 | 232 | 0.15 | Why? |
| Neovascularization, Pathologic | 1 | 2019 | 305 | 0.15 | Why? |
| Neoplasm Invasiveness | 1 | 2018 | 582 | 0.15 | Why? |
| Cervical Vertebrae | 1 | 2017 | 151 | 0.15 | Why? |
| Head | 1 | 2017 | 206 | 0.15 | Why? |
| Midwifery | 1 | 2021 | 384 | 0.15 | Why? |
| Liability, Legal | 1 | 2018 | 198 | 0.14 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2019 | 604 | 0.14 | Why? |
| Medical Errors | 1 | 2018 | 201 | 0.14 | Why? |
| Prednisolone | 1 | 2018 | 443 | 0.14 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.14 | Why? |
| Female | 23 | 2021 | 380317 | 0.14 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.14 | Why? |
| Rhinitis | 2 | 2019 | 626 | 0.14 | Why? |
| Hyperbaric Oxygenation | 1 | 2017 | 268 | 0.14 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.14 | Why? |
| Parent-Child Relations | 1 | 2018 | 384 | 0.13 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.13 | Why? |
| Autoimmune Diseases | 2 | 2018 | 1996 | 0.13 | Why? |
| Aged | 13 | 2021 | 215776 | 0.13 | Why? |
| Anesthesiologists | 1 | 2019 | 614 | 0.12 | Why? |
| Diagnostic Self Evaluation | 1 | 2017 | 394 | 0.12 | Why? |
| Brain Neoplasms | 1 | 2019 | 669 | 0.12 | Why? |
| Drug-Eluting Stents | 1 | 2018 | 562 | 0.12 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Adrenal Cortex Hormones | 3 | 2018 | 6537 | 0.12 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.11 | Why? |
| Occupations | 1 | 2017 | 733 | 0.11 | Why? |
| Zinc | 1 | 2019 | 817 | 0.11 | Why? |
| Adult | 14 | 2021 | 244371 | 0.11 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.11 | Why? |
| Autoimmunity | 1 | 2018 | 841 | 0.11 | Why? |
| Probiotics | 1 | 2019 | 694 | 0.11 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.11 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| Vitamins | 1 | 2019 | 1208 | 0.10 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.10 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.10 | Why? |
| Staphylococcal Infections | 1 | 2019 | 1099 | 0.10 | Why? |
| Health Education | 1 | 2021 | 1539 | 0.10 | Why? |
| Physical Therapy Modalities | 1 | 2018 | 1090 | 0.09 | Why? |
| Alcohol Drinking | 1 | 2021 | 1663 | 0.09 | Why? |
| Alzheimer Disease | 1 | 2019 | 1020 | 0.09 | Why? |
| Forecasting | 2 | 2020 | 4492 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.09 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.09 | Why? |
| Rome | 2 | 2021 | 497 | 0.09 | Why? |
| Bacteria | 1 | 2019 | 1897 | 0.09 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.09 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.09 | Why? |
| Attitude to Health | 1 | 2021 | 2002 | 0.09 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.08 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.08 | Why? |
| Patient Isolation | 1 | 2021 | 3182 | 0.08 | Why? |
| Tracheostomy | 1 | 2020 | 1963 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Child | 7 | 2019 | 70012 | 0.08 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.08 | Why? |
| Surveys and Questionnaires | 5 | 2021 | 43792 | 0.07 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.07 | Why? |
| Medical Oncology | 1 | 2021 | 3826 | 0.07 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.07 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.07 | Why? |
| Hospitals, Public | 2 | 2021 | 774 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Feminine Hygiene Products | 1 | 2021 | 10 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Pregnancy in Adolescence | 1 | 2021 | 22 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Amyloidogenic Proteins | 1 | 2020 | 30 | 0.06 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Hepatitis A Vaccines | 1 | 2021 | 52 | 0.05 | Why? |
| Epidermal Growth Factor | 1 | 2020 | 44 | 0.05 | Why? |
| Combined Modality Therapy | 2 | 2020 | 3395 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.05 | Why? |
| Acoustic Impedance Tests | 1 | 2019 | 16 | 0.05 | Why? |
| Tuberculosis Vaccines | 1 | 2021 | 89 | 0.05 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.05 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2018 | 88759 | 0.05 | Why? |
| Otoscopy | 1 | 2019 | 29 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Audiometry, Pure-Tone | 1 | 2019 | 64 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Progesterone | 1 | 2020 | 106 | 0.05 | Why? |
| Injection, Intratympanic | 1 | 2018 | 16 | 0.05 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.05 | Why? |
| Functional Laterality | 1 | 2019 | 57 | 0.05 | Why? |
| Frontal Sinus | 1 | 2018 | 20 | 0.05 | Why? |
| Hepatitis A | 1 | 2021 | 140 | 0.05 | Why? |
| HLA-B51 Antigen | 1 | 2018 | 5 | 0.05 | Why? |
| Auditory Threshold | 1 | 2018 | 32 | 0.05 | Why? |
| Hepatitis B Vaccines | 1 | 2021 | 245 | 0.05 | Why? |
| Vitamin E | 1 | 2019 | 128 | 0.05 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.05 | Why? |
| Acoustics | 1 | 2019 | 130 | 0.05 | Why? |
| Voice Quality | 1 | 2019 | 92 | 0.05 | Why? |
| Cell Nucleolus | 1 | 2018 | 59 | 0.05 | Why? |
| Catheters | 1 | 2018 | 93 | 0.05 | Why? |
| Quadriceps Muscle | 1 | 2018 | 50 | 0.04 | Why? |
| Dizziness | 1 | 2020 | 275 | 0.04 | Why? |
| Refuse Disposal | 1 | 2021 | 183 | 0.04 | Why? |
| Intraoperative Care | 1 | 2019 | 238 | 0.04 | Why? |
| Dilatation | 1 | 2018 | 181 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Etanercept | 1 | 2018 | 162 | 0.04 | Why? |
| Cochlear Implantation | 1 | 2018 | 89 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2019 | 835 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Organ Specificity | 1 | 2020 | 1070 | 0.04 | Why? |
| Cell Nucleus | 1 | 2018 | 399 | 0.04 | Why? |
| Tracheotomy | 1 | 2021 | 427 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2019 | 557 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.03 | Why? |
| Animals | 3 | 2019 | 78931 | 0.03 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.03 | Why? |
| Administration, Intranasal | 1 | 2019 | 1132 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Adalimumab | 1 | 2018 | 389 | 0.03 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.03 | Why? |
| Infliximab | 1 | 2018 | 502 | 0.03 | Why? |
| Accidental Falls | 1 | 2018 | 448 | 0.03 | Why? |
| Nasal Cavity | 1 | 2019 | 909 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2019 | 676 | 0.03 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.03 | Why? |
| Hepatitis B | 1 | 2021 | 888 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Steroids | 1 | 2018 | 904 | 0.03 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| Climate Change | 1 | 2021 | 901 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2020 | 1044 | 0.03 | Why? |
| Central Nervous System | 1 | 2018 | 701 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2018 | 658 | 0.03 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.03 | Why? |
| Brain | 2 | 2019 | 5133 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Sinusitis | 1 | 2019 | 649 | 0.03 | Why? |
| Professional Role | 1 | 2021 | 1280 | 0.03 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.03 | Why? |
| Flow Cytometry | 1 | 2019 | 2393 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Workload | 1 | 2020 | 1887 | 0.02 | Why? |
| Pregnancy Complications | 1 | 2021 | 1388 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Endothelial Cells | 1 | 2019 | 2048 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.02 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.02 | Why? |
| Autopsy | 1 | 2018 | 3495 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Infant | 2 | 2019 | 30274 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Tuberculosis | 1 | 2021 | 2895 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2021 | 2941 | 0.02 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Vitamin D | 1 | 2019 | 2904 | 0.02 | Why? |
| Patient Acceptance of Health Care | 1 | 2021 | 5002 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 13720 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |